BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37802294)

  • 21. Mutations affecting G-protein subunit α11 in hypercalcemia and hypocalcemia.
    Nesbit MA; Hannan FM; Howles SA; Babinsky VN; Head RA; Cranston T; Rust N; Hobbs MR; Heath H; Thakker RV
    N Engl J Med; 2013 Jun; 368(26):2476-2486. PubMed ID: 23802516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of HRAS mutations and absence of GNAQ or GNA11 mutations in deep penetrating nevi.
    Bender RP; McGinniss MJ; Esmay P; Velazquez EF; Reimann JD
    Mod Pathol; 2013 Oct; 26(10):1320-8. PubMed ID: 23599145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases.
    Lyu J; Wu Y; Li C; Wang R; Song H; Ren G; Guo W
    J Oral Pathol Med; 2016 Apr; 45(4):295-301. PubMed ID: 26399561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High frequency of GNA14, GNAQ, and GNA11 mutations in cherry hemangioma: a histopathological and molecular study of 85 cases indicating GNA14 as the most commonly mutated gene in vascular neoplasms.
    Liau JY; Lee JC; Tsai JH; Chen CC; Chung YC; Wang YH
    Mod Pathol; 2019 Nov; 32(11):1657-1665. PubMed ID: 31189994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncogenic GNAQ and GNA11 mutations in uveal melanoma in Chinese.
    Xu X; Wei WB; Li B; Gao F; Zhang Z; Jonas JB
    PLoS One; 2014; 9(10):e109699. PubMed ID: 25280020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma.
    Scholz SL; Möller I; Reis H; Süßkind D; van de Nes JAP; Leonardelli S; Schilling B; Livingstone E; Schimming T; Paschen A; Sucker A; Murali R; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3464-3470. PubMed ID: 28700778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GNA11-mutated Sturge-Weber syndrome has distinct neurological and dermatological features.
    Dompmartin A; van der Vleuten CJM; Dekeuleneer V; Duprez T; Revencu N; Désir J; Te Loo DMWM; Flucke U; Eijkelenboom A; Schultze Kool L; Vikkula M; Boon L
    Eur J Neurol; 2022 Oct; 29(10):3061-3070. PubMed ID: 35715928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in GNA11 in uveal melanoma.
    Van Raamsdonk CD; Griewank KG; Crosby MB; Garrido MC; Vemula S; Wiesner T; Obenauf AC; Wackernagel W; Green G; Bouvier N; Sozen MM; Baimukanova G; Roy R; Heguy A; Dolgalev I; Khanin R; Busam K; Speicher MR; O'Brien J; Bastian BC
    N Engl J Med; 2010 Dec; 363(23):2191-9. PubMed ID: 21083380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic and clinico-pathologic analysis of metastatic uveal melanoma.
    Griewank KG; van de Nes J; Schilling B; Moll I; Sucker A; Kakavand H; Haydu LE; Asher M; Zimmer L; Hillen U; Thompson JF; Scolyer RA; Schadendorf D; Murali R
    Mod Pathol; 2014 Feb; 27(2):175-83. PubMed ID: 23887304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient survival in uveal melanoma is not affected by oncogenic mutations in GNAQ and GNA11.
    Koopmans AE; Vaarwater J; Paridaens D; Naus NC; Kilic E; de Klein A;
    Br J Cancer; 2013 Jul; 109(2):493-6. PubMed ID: 23778528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Driver mutations in
    García-Mulero S; Fornelino R; Punta M; Lise S; Varela M; Del Carpio LP; Moreno R; Costa-García M; Rieder D; Trajanoski Z; Gros A; Alemany R; Piulats JM; Sanz-Pamplona R
    Oncoimmunology; 2023; 12(1):2261278. PubMed ID: 38126027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatic GNAQ Mutation is Enriched in Brain Endothelial Cells in Sturge-Weber Syndrome.
    Huang L; Couto JA; Pinto A; Alexandrescu S; Madsen JR; Greene AK; Sahin M; Bischoff J
    Pediatr Neurol; 2017 Feb; 67():59-63. PubMed ID: 27919468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma.
    Livingstone E; Zaremba A; Horn S; Ugurel S; Casalini B; Schlaak M; Hassel JC; Herbst R; Utikal JS; Weide B; Gutzmer R; Meier F; Koelsche C; Hadaschik E; Sucker A; Reis H; Merkelbach-Bruse S; Siewert M; Sahm F; von Deimling A; Cosgarea I; Zimmer L; Schadendorf D; Schilling B; Griewank KG
    Br J Dermatol; 2020 Nov; 183(5):928-939. PubMed ID: 32064597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative analysis of the GNAQ, GNA11, SF3B1, and EIF1AX driver mutations in melanoma and across the cancer spectrum.
    Johnson DB; Roszik J; Shoushtari AN; Eroglu Z; Balko JM; Higham C; Puzanov I; Patel SP; Sosman JA; Woodman SE
    Pigment Cell Melanoma Res; 2016 Jul; 29(4):470-3. PubMed ID: 27089234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mosaic GNA11 mutations and a second hit in KRAS in phakomatosis pigmentovascularis are associated with intraosseous arteriovenous malformations in the jaw.
    Sun Y; Su L; Rao Y; Wang Z; Wang D; Fan X; Cai 蔡韧 R
    J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):e484-e486. PubMed ID: 35080323
    [No Abstract]   [Full Text] [Related]  

  • 36. INPP5A phosphatase is a synthetic lethal target in GNAQ and GNA11-mutant melanomas.
    Elbatsh AMO; Amin-Mansour A; Haberkorn A; Textor C; Ebel N; Renard E; Koch LM; Groenveld FC; Piquet M; Naumann U; Ruddy DA; Romanet V; Martínez Gómez JM; Shirley MD; Wipfli P; Schnell C; Wartmann M; Rausch M; Jager MJ; Levesque MP; Maira SM; Manchado E
    Nat Cancer; 2024 Mar; 5(3):481-499. PubMed ID: 38233483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations.
    Chen X; Wu Q; Tan L; Porter D; Jager MJ; Emery C; Bastian BC
    Oncogene; 2014 Sep; 33(39):4724-34. PubMed ID: 24141786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity in Mitogen-Activated Protein Kinase (MAPK) Pathway Activation in Uveal Melanoma With Somatic GNAQ and GNA11 Mutations.
    Boru G; Cebulla CM; Sample KM; Massengill JB; Davidorf FH; Abdel-Rahman MH
    Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2474-2480. PubMed ID: 31173078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause.
    Zhou J; Azizan EAB; Cabrera CP; Fernandes-Rosa FL; Boulkroun S; Argentesi G; Cottrell E; Amar L; Wu X; O'Toole S; Goodchild E; Marker A; Senanayake R; Garg S; Åkerström T; Backman S; Jordan S; Polubothu S; Berney DM; Gluck A; Lines KE; Thakker RV; Tuthill A; Joyce C; Kaski JP; Karet Frankl FE; Metherell LA; Teo AED; Gurnell M; Parvanta L; Drake WM; Wozniak E; Klinzing D; Kuan JL; Tiang Z; Gomez Sanchez CE; Hellman P; Foo RSY; Mein CA; Kinsler VA; Björklund P; Storr HL; Zennaro MC; Brown MJ
    Nat Genet; 2021 Sep; 53(9):1360-1372. PubMed ID: 34385710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cloning, expression pattern, chromosomal localization, and evolution analysis of Porcine gnaq, gna11, and gna14.
    Chen H; Yao W; Jin D; Xia T; Chen X; Lei T; Zhou L; Yang Z
    Biochem Genet; 2008 Aug; 46(7-8):398-405. PubMed ID: 18330691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.